Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert H. Boone is active.

Publication


Featured researches published by Robert H. Boone.


Catheterization and Cardiovascular Interventions | 2016

Angiographic appearance of spontaneous coronary artery dissection with intramural hematoma proven on intracoronary imaging

Jacqueline Saw; G.B. John Mancini; Karin H. Humphries; Anthony Fung; Robert H. Boone; Andrew Starovoytov; Eve Aymong

The pathognomonic appearance of multiple radiolucent lumen on angiography is used to diagnose spontaneous coronary artery dissection (SCAD). However, this finding is absent in >70% of SCAD, in which case optical coherence tomography (OCT) or intravascular ultrasound (IVUS) is useful to assess arterial wall integrity.


Eurointervention | 2014

Transcatheter mitral valve implantation with Tiara bioprosthesis

Anson Cheung; Dion Stub; Robert Moss; Robert H. Boone; Jonathon Leipsic; Stefan Verheye; Shmuel Banai; John G. Webb

Mitral valve surgery is the gold standard therapy for severe mitral regurgitation, but can be associated with significant morbidity and mortality. Percutaneous mitral leaflet repair has recently been established as a viable alternative to surgery, but many patients are ineligible and repair may not be optimal. Transcatheter mitral valve implantation may be an alternate therapeutic option, particularly for high-risk patients. We outline the initial preclinical and first-in-human experience with the Tiara transapical mitral valve implantation system, highlighting the ease of implantation, proven feasibility and excellent haemodynamic performance.


European Journal of Cardiovascular Nursing | 2014

Integrating a palliative approach in a transcatheter heart valve program: Bridging innovations in the management of severe aortic stenosis and best end-of-life practice

Sandra Lauck; Ella Garland; L. Achtem; J. Forman; Jennifer Baumbusch; Robert H. Boone; Anson Cheung; Jian Ye; David A. Wood; John G. Webb

Severe aortic stenosis (AS) is the most prevalent structural heart disease and affects primarily older adults in their last decade of life. If the risk for surgery is high, transcatheter aortic valve implantation (TAVI) is the treatment of choice for many patients with suitable anatomy who are likely to derive significant benefit from this innovative and minimally invasive approach. In a large transcatheter heart valve (THV) centre that offers TAVI as one of the treatment options, of 565 consecutive referrals for the assessment of eligibility for TAVI over 18 months, 78 (14%) were deemed unsuitable candidates for TAVI or higher risk surgery by the interdisciplinary Heart Team because of their advanced disease, excessive frailty or comorbid burden. Concerns were raised for patients for whom TAVI is not an option. The integration of a palliative approach in a THV program offers opportunities to adopt best end-of-life practices while promoting innovative approaches for treatment. An integrated palliative approach to care focuses on meeting a patient’s full range of physical, psychosocial and spiritual needs at all stages of a life-limiting illness, and is well suited for the severe AS and TAVI population. A series of interventions that reflect best practices and current evidence were adopted in collaboration with the Palliative Care Team and are currently under evaluation in a large TAVI centre. Changes include the introduction of a palliative approach in patient assessment and education, the measurement of symptoms, improved clarity about responsibility for communication and follow-up, and triggering referrals to palliative care services.


Jacc-cardiovascular Interventions | 2016

Pre-Disposing and Precipitating Factors in Men With Spontaneous Coronary Artery Dissection

Peter Fahmy; Roshan Prakash; Andrew Starovoytov; Robert H. Boone; Jacqueline Saw

Spontaneous coronary artery dissection (SCAD) is an infrequent but important cause of myocardial infarction (MI) in younger women. The underlying cause, presentation, and natural history of SCAD in women are increasingly being described because >90% of cases affect women. However, SCAD in men is


Circulation | 2013

Impact of Preoperative Moderate/Severe Mitral Regurgitation on 2-Year Outcome after Transcatheter and Surgical Aortic Valve Replacement: Insight from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial Cohort A

Marco Barbanti; John G. Webb; Rebecca T. Hahn; Ted Feldman; Robert H. Boone; Craig R. Smith; Susheel Kodali; Alan Zajarias; Christopher R. Thompson; Philip Green; Vasilis Babaliaros; Raj Makkar; Wilson Y. Szeto; Pamela S. Douglas; Tom McAndrew; Irene Hueter; D. Craig Miller; Martin B. Leon

Background— The effect of preoperative mitral regurgitation (MR) on clinical outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) is controversial. This study sought to examine the impact of moderate and severe MR on outcomes after TAVR and surgical aortic valve replacement (SAVR). Methods and Results— Data were drawn from the randomized Placement of Aortic Transcatheter Valve (PARTNER) Trial cohort A patients with severe, symptomatic aortic stenosis undergoing either TAVR (n=331) or SAVR (n=299). Both TAVR and SAVR patients were dichotomized according to the degree of preoperative MR (moderate/severe versus none/mild). At baseline, moderate or severe MR was reported in 65 TAVR patients (19.6%) and 63 SAVR patients (21.2%). At 30 days, among survivors who had isolated SAVR/TAVR, moderate/severe MR had improved in 25 SAVR patients (69.4%) and 30 TAVR patients (57.7%), was unchanged in 10 SAVR patients (27.8%) and 19 TAVR patients (36.5%), and worsened in 1 SAVR patient (2.8%) and 4 TAVR patients (5.8%; all P=NS). Mortality at 2 years was higher in SAVR patients with moderate or severe MR than in those with mild or less MR (49.8% versus 28.1%; adjusted hazard ratio, 1.73; 95% confidence interval, 1.01–2.96; P=0.04). In contrast, MR severity at baseline did not affect mortality in TAVR patients (37.0% versus 32.7%, moderate/severe versus none/mild; hazard ratio, 1.14; 95% confidence interval, 0.72–1.78; P=0.58; P for interaction=0.05). Conclusions— Both TAVR and SAVR were associated with a significant early improvement in MR in survivors. However, moderate or severe MR at baseline was associated with increased 2-year mortality after SAVR but not after TAVR. TAVR may be a reasonable option in selected patients with combined aortic and mitral valve disease. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00530894.Background— The effect of preoperative mitral regurgitation (MR) on clinical outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) is controversial. This study sought to examine the impact of moderate and severe MR on outcomes after TAVR and surgical aortic valve replacement (SAVR).nnMethods and Results— Data were drawn from the randomized Placement of Aortic Transcatheter Valve (PARTNER) Trial cohort A patients with severe, symptomatic aortic stenosis undergoing either TAVR (n=331) or SAVR (n=299). Both TAVR and SAVR patients were dichotomized according to the degree of preoperative MR (moderate/severe versus none/mild). At baseline, moderate or severe MR was reported in 65 TAVR patients (19.6%) and 63 SAVR patients (21.2%). At 30 days, among survivors who had isolated SAVR/TAVR, moderate/severe MR had improved in 25 SAVR patients (69.4%) and 30 TAVR patients (57.7%), was unchanged in 10 SAVR patients (27.8%) and 19 TAVR patients (36.5%), and worsened in 1 SAVR patient (2.8%) and 4 TAVR patients (5.8%; all P =NS). Mortality at 2 years was higher in SAVR patients with moderate or severe MR than in those with mild or less MR (49.8% versus 28.1%; adjusted hazard ratio, 1.73; 95% confidence interval, 1.01–2.96; P =0.04). In contrast, MR severity at baseline did not affect mortality in TAVR patients (37.0% versus 32.7%, moderate/severe versus none/mild; hazard ratio, 1.14; 95% confidence interval, 0.72–1.78; P =0.58; P for interaction=0.05).nnConclusions— Both TAVR and SAVR were associated with a significant early improvement in MR in survivors. However, moderate or severe MR at baseline was associated with increased 2-year mortality after SAVR but not after TAVR. TAVR may be a reasonable option in selected patients with combined aortic and mitral valve disease.nnClinical Trial Registration— URL: . Unique identifier: [NCT00530894][1].nn# Clinical Perspective {#article-title-27}nn [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT00530894&atom=%2Fcirculationaha%2F128%2F25%2F2776.atom


Canadian Journal of Cardiology | 2013

Structural Heart Diseases Interventional Training in Canada

Konstantinos Marmagkiolis; Faisal Alqoofi; Anita W. Asgar; Robert H. Boone; Mehmet Cilingiroglu

Structural heart disease interventions have evolved into an important component of interventional cardiology fellowship programs worldwide. Given the complexity of such interventions, the breadth of knowledge needed for optimal patient selection and postprocedural management, and the skills to perform them efficiently, advanced training has become mandatory. Postgraduate medical training in Canada has always been on the cutting edge of new technology, and excellent care is provided to the increasing population of adult patients with congenital heart disease. The current survey sought to collect relevant information and assess the opinion of interventional cardiology program directors in Canada regarding training in structural interventions. Our study reports the approximate number of structural procedures performed by interventional cardiology fellows in Canadian interventional cardiology fellowship programs, the form of the structural training, and the suggestions of program directors who are actively trying to integrate structural training into interventional cardiology fellowship programs.


CJEM | 2017

A comprehensive regional clinical and educational ECPR protocol decreases time to ECMO in patients with refractory out-of-hospital cardiac arrest

Brian Grunau; Sarah Carrier; Jamil Bashir; William Dick; Luke Harris; Robert H. Boone; Dan Kalla; Frank X. Scheuermeyer; Brian Twaites; Ron Straight; James G Abel; Ken McDonald; Ruth MacRedmond; David Agulnik; Joe Finkler; Jeanne MacLeod; Jim Christenson; Anson Cheung

OBJECTIVEnExtracorporeal membrane oxygenation within CPR (ECPR) may improve survival for refractory out-of-hospital cardiac arrest (OHCA). We developed a prehospital, emergency department (ED), and hospital-based clinical and educational protocol to improve the key variable of time-to-ECPR (TTE).nnnMETHODSnIn a single urban health region we involved key prehospital, clinical, and administrative stakeholders over a 2-year period, to develop a regional ECPR program with destination to a single urban tertiary care hospital. We developed clear and reproducible inclusion criteria and processes, including measures of program efficiency. We conducted seminars and teaching modules to paramedics and hospital-based clinicians including monthly simulator sessions, and performed detailed reviews of each treated case in the form of report cards. In this before-and-after study we compared patients with ECPR attempted prior to, and after, protocol implementation. The primary outcome was TTE, defined as the time of initial professional CPR to establishment of extracorporeal circulation. We compared the median TTE for patients in the two groups using the Wilcoxon signed rank test.nnnRESULTSnFour patients were identified prior to the protocol and managed in an ad hoc basis; for nine patients the protocol was utilized. Overall favourable neurological outcomes among ECPR-treated patients were 27%. The median TTE was 136 minutes (IQR 98 - 196) in the pre-protocol group, and 60 minutes (IQR 49 - 81) minutes in the protocol group (p=0.0165).nnnCONCLUSIONnAn organized clinical and educational protocol to initiate ECPR for patients with OHCA is feasible and significantly reduces the key benchmark of time-to-ECPR flows.


Cardiovascular Revascularization Medicine | 2016

Clinical characteristics, angiographic findings, and one-year outcome of 101 consecutive stent thrombosis cases in British Columbia

Mathieu Lempereur; Nigussie Bogale; Peter Fahmy; Imran Shiekh; Andrew Starovoytov; Eve Aymong; Robert H. Boone; Simon Robinson; Jahangir Charania; Richard Townley; Christopher R. Thompson; Andrew Kmetic; Lillian Ding; Anthony Fung

BACKGROUNDnStent thrombosis (ST) is rare, but is associated with significant morbidity and mortality.nnnMETHODSnWe analyzed data from the British Columbia (BC) Registry from April 2011-January 2012.nnnRESULTSn101 ST cases were reported and verified. Based on timing, ST was considered early (≤30days) in 35.6%, late (>30days-1year) in 17.8% and very late (>1year) in 46.5%. The majority (68.5%) presented with STEMI, and the remaining with non-STEMI (31.5%). Most vessels were functionally occluded (TIM1 flow grade ≤1 in 67.1%). Thrombus burden was high (TIMI thrombus grade ≥4 in 77.2%). Aspiration thrombectomy was performed in 41% of cases. New stents were implanted in 62.4% cases. Intra-coronary imaging was low (11%). At the original stent implantation, STEMI was the clinical presentation in 39.6%, the lesion was complex in 62.1%, and thrombus was visualized in 23.0%. Prognosis after ST was unfavorable with high mortality (11.9% at 30days and 16.8% at one year), and further revascularization (5.0% repeat PCI and 6.9% coronary artery bypass graft surgery). Early ST was associated with worse clinical outcome compared to late/very late ST: 30-day mortality at 22.2% versus 6.2% (p=0.02), and 1-year mortality at 27.8% versus 10.8% (p=0.05).nnnCONCLUSIONSnIn this prospective registry from BC, all ST presented with myocardial infarction, and the majority was treated with emergency PCI. Additional stents were commonly implanted with infrequent use of intracoronary imaging. Mortality rate was higher for early ST in comparison with late/very late ST. A comprehensive approach should be developed to treat this difficult complication.


Archive | 2009

Vascular Access: Femoral, Radial, Brachial, and Direct Carotid Approach

Robert H. Boone; Ravish Sachar

Vascular access is the cornerstone of all endovascular procedures. Common femoral artery puncture is the most common route of access and, when performed properly, permits successful carotid stent deployment in over 98% of cases. However, access site complications are the most frequent cause of morbidity, and their incidence can be reduced with proper technique. Furthermore, radial and brachial approaches may occasionally be required, or may offer an increased chance of procedure success. Current technology has allowed the development of better equipment which in turn has meant that direct carotid puncture is rarely (if ever) required.


Canadian Journal of Cardiology | 2013

Stability of Non Culprit Vessel Fractional Flow Reserve in Patients With St-Segment Elevation Myocardial Infarction

David Wood; R. Poulter; Robert H. Boone; C. Owens; Andrew Starovoytov; I. Lim; Nigussie Bogale; Mathieu Lempereur; I. Shiekh; C. Buller; Karin H. Humphries; G. Mancini; John A. Cairns; G. Wong

Collaboration


Dive into the Robert H. Boone's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anson Cheung

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karin H. Humphries

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

David A. Wood

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jacqueline Saw

Vancouver General Hospital

View shared research outputs
Top Co-Authors

Avatar

Robert Moss

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

John Webb

Federal University of São Paulo

View shared research outputs
Top Co-Authors

Avatar

Anthony Fung

University of British Columbia

View shared research outputs
Researchain Logo
Decentralizing Knowledge